Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.
Rapold, H J
Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group. [electronic resource] - Circulation Mar 1992 - 928-34 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0009-7322
10.1161/01.cir.85.3.928 doi
Coronary Vessels--physiopathology
Fibrinopeptide A--analysis
Heparin--therapeutic use
Humans
Myocardial Infarction--blood
Recurrence
Thrombin--metabolism
Thrombolytic Therapy
Tissue Plasminogen Activator--therapeutic use
Vascular Patency--physiology
Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group. [electronic resource] - Circulation Mar 1992 - 928-34 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0009-7322
10.1161/01.cir.85.3.928 doi
Coronary Vessels--physiopathology
Fibrinopeptide A--analysis
Heparin--therapeutic use
Humans
Myocardial Infarction--blood
Recurrence
Thrombin--metabolism
Thrombolytic Therapy
Tissue Plasminogen Activator--therapeutic use
Vascular Patency--physiology